SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NPSP NPS Pharmaceutical
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
363 40 0 NPSP
Emcee:  Jim Langdon Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
313gs: NPS Pharmaceuticals, Inc. (NPSP): New trials on Preos needed. Focus shifted mopgcw-8/8/2006
312Interestingly, management has been buying, probably in spite of knowing the lawstuck-7/15/2006
311>>Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class Actiontuck-7/15/2006
310Citi: NPSP: NPS Announces Restructuring; Preos Outlook Remains in Limbo mopgcw-6/22/2006
309>>NPS Announces Aggressive Plan to Restructure Operations and Cut Costs Motuck-6/12/2006
308Teduglutide PIIa results in Crohn's; misses endpoint but highest dose group tuck-5/22/2006
307Option grant, not a purchase. Heads he wins, tails he wins. Nice being a ceo. rkrw-5/16/2006
306Tony Coles buys 200,000 shares on the open market for $5.27/sh. BJBiotech Jim-5/15/2006
305Citi: NPSP: Further Delay for Preos; Reducing Rating to Hold & Tgt Price mopgcw-5/5/2006
304NPS Pharma Shares Tumble on PREOS News Tuesday May 2, 5:31 pm ET NPS Pharmaceumopgcw-5/3/2006
303NPS Pharmaceuticals Reports First Quarter 2006 Operating Results Tuesday May 2,mopgcw-5/3/2006
302Long term exposure to Fosamax linked to rare disease of the jaw; lawyers salivattuck-4/12/2006
301George- Thanks for the update provided by Citi. I think the bigger issue of Biotech Jim-4/8/2006
300Citi: 3.27.06 We hosted a Biotech Day event today where key management team memmopgcw-4/8/2006
299So in roughly a month we find out how much longer we have to wait, i.e. Class 1 tuck-3/30/2006
298citi: NPSP: Uncertainty Remains But Rxn to Approvable Ltr May Be Overdone BUY mopgcw-3/15/2006
297Should have noted that that was from Merrill, sorrytom pope-3/12/2006
296This was from 3/6, just found it today. In the light of the swoon on Friday, nottom pope-3/12/2006
295mstar: Analyst Note 03-10-06 NPS Pharmaceuticals investors held their breath Frmopgcw-3/12/2006
294s&p: NPSP was down sharply today on news of FDA approvable letter for Preosmopgcw-3/11/2006
293Thanks Tom and Jack. I have no idea what's smart here and I realize therefred hayes-3/10/2006
292Somebody mentioned that NPSP is an "institutional favorite". That'tom pope-3/10/2006
291Fred: I have got to get smarter on these bio-events. Sell off a bunch before tJack@SI-3/10/2006
290Not surprised at less than full approval. But 36 percent drop? Anybody think thifred hayes-3/10/2006
289Approvable letter from FDA. Perhaps some delays before Preos is launched. biz.Jack@SI-3/10/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News